8 assets in Musculoskeletal System Disorder

Therapeutic assets addressing Musculoskeletal System Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tirzepatide Musculoskeletal System Disorder	Pennington Biomedical Research Center	P4	BB (65)
Amoxicillin Musculoskeletal System Disorder	Bart Koes	P3	B (60)
Aoc 1044 Musculoskeletal System Disorder	Avidity Biosciences, Inc.	P3	B (60)
Enobosarm Musculoskeletal System Disorder	Veru Inc.	P2	CCC (53)
Semaglutide Musculoskeletal System Disorder	Veru Inc.	P2	CCC (53)
Serostim Musculoskeletal System Disorder	Center for Neurological Studies	P2	CCC (53)
Primepro™/ Primemsk™ Musculoskeletal System Disorder	Thomas Advanced Medical LLC	P1/2	CCC (48)
Anastrozole Musculoskeletal System Disorder	ECOG-ACRIN Cancer Research Group	N/A	D (30)